Vancomycin: a reappraisal.
作者信息
Ahmad R, Raichura N, Kilbane V, Whitfield E
出版信息
Br Med J (Clin Res Ed). 1982 Jun 26;284(6333):1953-4. doi: 10.1136/bmj.284.6333.1953-b.
Abstract
摘要
相似文献
1
Vancomycin: a reappraisal.万古霉素：重新评估
Br Med J (Clin Res Ed). 1982 Jun 26;284(6333):1953-4. doi: 10.1136/bmj.284.6333.1953-b.
2
Recent changes in vancomycin use in renal failure.肾衰竭患者万古霉素使用的近期变化。
Kidney Int. 2010 May;77(9):760-4. doi: 10.1038/ki.2010.35. Epub 2010 Feb 24.
3
Vancomycin therapy in severe staphylococcal infections.
Rev Infect Dis. 1981 Nov-Dec;3 suppl:S236-9.
4
Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis.万古霉素用于接受定期血液透析患者的葡萄球菌分流部位感染
Br Med J. 1970 Jul 11;3(5714):80-2. doi: 10.1136/bmj.3.5714.80.
5
Vancomycin revisited: a reappraisal of clinical use.再探万古霉素：临床应用的重新评估
Crit Care Clin. 2008 Apr;24(2):393-420, x-xi. doi: 10.1016/j.ccc.2007.12.012.
6
Staphylococcus aureus with reduced susceptibility to vancomycin in a dialysis graft.一株对万古霉素敏感性降低的金黄色葡萄球菌存在于透析移植物中。
Clin Infect Dis. 2005 Aug 15;41(4):566-7. doi: 10.1086/432122.
7
Vancomycin levels, efficacy, and toxicity.万古霉素血药浓度、疗效及毒性。
Arch Intern Med. 2007 Jun 11;167(11):1207; author reply 1208-9. doi: 10.1001/archinte.167.11.1207-a.
8
[New guidelines for vancomycin in staphylococcal infections].[葡萄球菌感染中万古霉素的新指南]
Lakartidningen. 2010;107(11):742.
9
Chest pain--another adverse reaction to vancomycin.胸痛——万古霉素的另一种不良反应。
Chest. 1990 Jun;97(6):1504. doi: 10.1378/chest.97.6.1504a.
10
Vancomycin-induced interstitial nephritis.万古霉素诱导的间质性肾炎。
Am J Med. 1988 Mar;84(3 Pt 1):561-2. doi: 10.1016/0002-9343(88)90287-2.
引用本文的文献
1
Treatment of paediatric vancomycin intoxication: a case report and review of the literature.儿童万古霉素中毒的治疗：一例病例报告及文献综述
NDT Plus. 2010 Jun;3(3):260-264. doi: 10.1093/ndtplus/sfq016. Epub 2010 Mar 17.
2
Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.鸟分枝杆菌-胞内分枝杆菌与获得性免疫缺陷综合征
Antimicrob Agents Chemother. 1987 Jun;31(6):969. doi: 10.1128/AAC.31.6.969.
3
Lack of effect of vancomycin and gentamicin on auditory function in guinea pigs.万古霉素和庆大霉素对豚鼠听觉功能无影响。
Antimicrob Agents Chemother. 1996 May;40(5):1098-103. doi: 10.1128/AAC.40.5.1098.
4
Experimental, clinical and preventive aspects of ototoxicity.耳毒性的实验、临床及预防方面
Eur Arch Otorhinolaryngol. 1994;251(7):375-92. doi: 10.1007/BF00181963.
5
Pharmacokinetic optimisation of vancomycin therapy.万古霉素治疗的药代动力学优化
Clin Pharmacokinet. 1995 Apr;28(4):327-42. doi: 10.2165/00003088-199528040-00005.
6
Clinical pharmacokinetics of vancomycin.万古霉素的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82. doi: 10.2165/00003088-198611040-00001.
7
Vancomycin ototoxicity and nephrotoxicity. A review.万古霉素的耳毒性和肾毒性。综述。
Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):376-86. doi: 10.1007/BF03259891.
8
Vancomycin- and erythromycin-induced hearing loss in humans.万古霉素和红霉素所致的人类听力损失
Antimicrob Agents Chemother. 1989 Jun;33(6):791-6. doi: 10.1128/AAC.33.6.791.
9
Clinical pharmacokinetics of teicoplanin.替考拉宁的临床药代动力学
Clin Pharmacokinet. 1990 Mar;18(3):184-209. doi: 10.2165/00003088-199018030-00002.
本文引用的文献
1
Method for estimating individual drug-dosage regimens. An application of the occupancy principle.估算个体药物剂量方案的方法。占有率原理的一种应用。
Lancet. 1969 Oct 11;2(7624):771-3. doi: 10.1016/s0140-6736(69)90480-2.
Zotero 插件